Salutary Effect of Pegylated Interferona in PV and ET As Evaluated by Quantitation of Pre-JAK2V617F and JAK2V617F-Bearing Stem Cells and Granulocytes and Correlation with Circulating Regulatory T Cells and HSC Cell Cycle Status
Sabina Świerczek(University of Utah), Josef T. Prchal(Huntsman Cancer Institute), Margaret A. Goodell(Baylor College of Medicine), Soo Jin Kim, Ching-Chieh Shen(Baylor College of Medicine), Todd W. Kelley(University Hospitals Cleveland Medical Center), Katherine Y. King(Baylor College of Medicine), Kimberly Hickman(University of Utah), Mohamed E. Salama(The University of Texas at San Antonio Health Science Center)
Cited by 4
Related Papers
Epigenomic Profiling of Young and Aged HSCs Reveals Concerted Changes during Aging that Reinforce Self-Renewal
|Cell stem cell|2014|703
MYC Drives Progression of Small Cell Lung Cancer to a Variant Neuroendocrine Subtype with Vulnerability to Aurora Kinase Inhibition
|Cancer Cell|2017|619
Spectrum of Epithelial Neoplasms in End-Stage Renal Disease
|The American Journal of Surgical Pathology|2006|484
A genetic mechanism for Tibetan high-altitude adaptation
|Nature Genetics|2014|441
PPM1D Mutations Drive Clonal Hematopoiesis in Response to Cytotoxic Chemotherapy
|Cell stem cell|2018|423